MOG and neoplasm: Per the 2021 paraneoplastic neurologic syndrome (PNS) diagnostic criteria, MOG‐IgG is designated a low‐risk antibody,2 and rare cases of MOGAD with concomitant neoplasm have been reported.3, 4